TerSera Therapeutics Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- TerSera Therapeutics's estimated annual revenue is currently $22.7M per year.
- TerSera Therapeutics's estimated revenue per employee is $201,000
- TerSera Therapeutics has 113 Employees.
- TerSera Therapeutics grew their employee count by 20% last year.
- TerSera Therapeutics currently has 1 job openings.
|Lora Blackowicz||Vice President, Pharmacovigilance|
|Rick Crowley||Senior Vice President Operations And Quality Assurance|
|Kenton Morneau||VP Information Technology|
|Vicky Papoutsis||Evp Business Development|
|Patricia Sandoval||National Reimbursement Manager|
|Taryn Stinson||Director, Marketing|
|Courtney Drossos||Key Account Manager, Oncology|
|Anthony Anichini||Accounting Manager|
|Danielle Cass||Key Account Manager|
|Ellen Tonn||Director Regulatory Operations|
What Is TerSera Therapeutics?
TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Our mission is to market products which truly make a difference for patients. Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Care One Pharma...||$8.4M||42||24%||N/A|
|Firma Clinical ...||$16.7M||83||0%||N/A|
TerSera Therapeutics News
Goserelin Market SWOT Analysis including key players AstraZeneca, TerSera Therapeutics, Luye Pharma A Comprehensive Study exploring ...
Meloxicam Drug Market Latest Trend with Top key players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung ...
Plenty of Opportunities in Meloxicam Drug Market Studied in Detail along with Top Companies as Boehringer-Ingelheim, TerSera Therapeutics, ...